Introduction
Thyroid storm is an uncommon but serious and potentially fatal consequence of hyperthyroidism, characterised by an abrupt escalation of thyrotoxic symptoms.1 When an overactive thyroid causes hypermetabolism, it can cause multiple organ failure or cardiac arrest, which is a medical emergency. Thyroid storm needs prompt medical attention and cautious long-term management because mortality rates might reach 10–20% even with treatment.1 It is impossible to overestimate the significance of long-term care following thyroid storm stabilisation. Although uncommon, with an incidence rate of 0.2 per 100,000 people, it has a high mortality rate of 20–30%.3 The leading cause of thyroid storm is Graves' disease.1 The thyroid gland is stimulated by the development of antibodies in this autoimmune disease, which results in an overabundance of thyroid hormones. The usual course of treatment for Graves' disease is thyroidectomy, radioactive iodine therapy, or antithyroid drugs.1,2
Addressing the underlying thyroid condition is essential for preventing recurrence and guaranteeing the patient's general health and well-being, even when the acute crisis may be treated with intense care and focused therapies.2 The goals of long-term management techniques are to alleviate symptoms, prevent overtreatment, and recover and maintain a euthyroid condition. Multiple thyroid gland nodules that function autonomously contribute to toxic multinodular goitre, which causes an overabundance of hormones.4 Depending on the severity and unique patient characteristics, long-term treatment may involve radioactive iodine therapy, antithyroid drugs, or surgery.4 Thyrotoxicosis and thyroid storm can result from a single hyperfunctioning thyroid nodule, known as a solitary toxic adenoma.5 Long-term management treatment choices for toxic multinodular goitre are comparable.
Long-term management after thyroid storm
Patients recuperating from thyroid storms, especially those with Graves' illness, are frequently treated with antithyroid medications (ATDs) as their first line of treatment. Methimazole (MMI) and propylthiouracil (PTU) are the two main drugs that are used.2 Methimazole is typically chosen over propylthiouracil because it is less likely to cause hepatotoxicity. PTU, on the other hand, is preferred in the first trimester of pregnancy and for treating thyroid storm because it can prevent T4 from being converted to T3.2 Treatment with ATD typically lasts 12–18 months, or until thyroid-stimulating receptor antibodies (TRAb) are no longer detectable.2 During ATD therapy, routine monitoring is essential. Agranulocytosis and liver toxicity are two possible adverse effects that doctors need to be aware of. Based on thyroid function testing, dose modifications are made to maintain a euthyroid state. Throughout ATD treatment, routine monitoring is essential. Healthcare professionals need to be on the lookout for any adverse effects, including liver damage and agranulocytosis. To maintain an euthyroid condition, dose modifications are done in response to thyroid function tests.
Definitive treatment is usually advised for individuals who relapse after finishing a course of ATDs. Continuous long-term low-dose MMI, however, may be a viable alternate management approach in certain circumstances.6
With success rates above 80% following a single dosage, RAI therapy is a proven treatment for hyperthyroidism. This entails the administration of radioactive iodine (I-131), which is destroyed by hyperactive thyroid tissue and is concentrated by the thyroid gland. Despite its great efficacy, RAI treatment frequently results in irreversible hypothyroidism, requiring thyroid hormone replacement for the rest of one's life.7 Patients with mild or active orbitopathy undergoing RAI should get steroid prophylaxis, and it is contraindicated in patients with active or severe Graves' ophthalmopathy.6
Another effective treatment is a thyroidectomy, which involves surgically removing the thyroid gland.2 It is especially recommended in situations involving severe ophthalmopathy, pregnancy, or huge goiters. Although thyroidectomies offer quick and effective management of hyperthyroidism, they also include surgical risks and cause irreversible hypothyroidism.2
Following a thyroidectomy, postoperative care includes close observation for any possible side effects, including hypocalcemia.8 Patients can avoid insufficient calcium by taking vitamin D and calcium supplements. Furthermore, individuals who have a total thyroidectomy will need to take levothyroxine for thyroid hormone replacement treatment for the rest of their lives.8
Beta-blockers are essential for short-term thyroid storm treatment and long-term management of its symptoms.9 These drugs aid in the management of tachycardia, tremors, and anxiety, which are adrenergic symptoms of thyrotoxicosis.9 Even after starting ATDs or final therapy, beta-blockers may be used in long-term maintenance for enduring symptoms. They offer symptomatic relief in situations where full euthyroidism is difficult to attain or while waiting for thyroid hormone levels to return to normal.10
Monitoring and follow-up
The routine evaluation of thyroid function via blood testing is the cornerstone of long-term care following thyroid storm. Triiodothyronine (T3), free thyroxine (T4), and thyroid-stimulating hormone (TSH) are commonly measured in these tests. These tests are often conducted more regularly in the first few months after thyroid storm and may be spread out as the patient stabilises, however, the frequency may vary based on the patient's clinical situation and treatment plan. Serum free T3 and T4 levels should be checked regularly in the initial post-thyroid storm period until an euthyroid condition is attained.11 Testing can be done less frequently after it has stabilised. Thyroid function tests are usually conducted every 4-6 weeks for individuals using antithyroid medications (ATDs), such as methimazole or propylthiouracil. As the disease stabilises, the interval is progressively increased to every three to six months.6
It's crucial to remember that even when free T4 and T3 levels have been restored to normal, TSH levels may continue to be suppressed for several months following the resolution of the thyroid storm. Therefore, when adjusting the dosage of ATDs in the early stages of treatment, doctors should mostly depend on free T4 and T3 levels.6
A crucial component of long-term therapy of hyperthyroidism is being alert for possible recurrence. Relapse can happen years after ATD cessation, however, it usually happens in the first 6–12 months.6 When treatment ends, patients who have big goitres, severe hyperthyroidism, or consistently high titers of TSH receptor antibodies (TRAb) are more likely to relapse.6
It is advised to assess TRAb levels regularly, as this helps determine whether individuals can be weaned off medication; normal levels suggest a higher likelihood of remission.6 Thyroidectomy or definitive treatment with radioactive iodine (RAI) is typically advised if a patient relapses after finishing a course of ATDs. On the other hand, long-term, low-dose methimazole may be an alternate management approach in certain circumstances.2,6 It is important to educate patients about the symptoms of recurrent hyperthyroidism, including palpitations, tremor, heat sensitivity, and weight loss. They should seek medical help immediately if these symptoms appear.12
Although the recurrence of hyperthyroidism is frequently the main concern following thyroid storm, it is also critical to keep an eye out for the emergence of hypothyroidism, especially in individuals who have had thyroidectomy or definitive therapy with RAI. Lifelong thyroid hormone replacement is required because radioactive iodine therapy frequently results in persistent hypothyroidism.6 Likewise, individuals who get a total thyroidectomy will need to take levothyroxine. Although the recurrence of hyperthyroidism is often the main concern following thyroid storm, it's also critical to keep an eye out for the emergence of hypothyroidism, especially in individuals who have had thyroidectomy or definitive therapy with RAI.
Lifelong thyroid hormone replacement is required because radioactive iodine therapy frequently results in persistent hypothyroidism. Likewise, individuals who get a total thyroidectomy will need to take levothyroxine for the rest of their lives. To guarantee proper hormone replacement in these situations and prevent both overtreatment and undertreatment, routine monitoring of TSH and free T4 levels is crucial.
Although it is less frequent, hypothyroidism can develop in patients on ATD treatment. Frequent thyroid function tests will assist in detecting this shift, enabling prompt therapy modification.
for the rest of their lives. Routine monitoring of TSH and free T4 levels is crucial to guarantee proper hormone replacement and prevent over- and undertreatment.6 Although less frequent, hypothyroidism can develop in patients on ATD treatment. Frequent thyroid function tests will assist in detecting this shift, enabling prompt therapy modification.13
Managing the complications
Patients who have had a thyroid storm are more likely to have cardiovascular problems because thyroid hormones have a significant impact on the circulatory system. Heart failure and atrial fibrillation are the two main issues. A frequent side effect of thyrotoxicosis, especially in elderly people, is atrial fibrillation. The recommended medication for regulating heart rate in atrial fibrillation linked to hyperthyroidism, particularly thyroid storm, is beta-blockers.14 More drastic measures can be required in certain situations. In patients with atrial fibrillation and thyroid storm, for example, intravenous amiodarone has been effectively used to reduce the fast heart rate. However, due to the possibility of thyroid toxicity, its use needs to be closely managed.14
Thyroid storms can also result in heart failure, another dangerous cardiovascular consequence. High-output cardiac failure and, in extreme situations, cardiogenic shock can result from thyrotoxicosis.15 Regular cardiac examinations, such as echocardiograms to evaluate left ventricular function, should be part of long-term care. When the underlying thyroid condition is properly treated, heart function frequently improves in cases with thyroid-induced cardiomyopathy.16
Thyrotoxicosis can significantly impair bone health, raising the risk of fractures and osteoporosis. Long-term increased thyroid hormone levels may increase patients' risk of osteoporosis and low bone density. Research indicates a possible elevated risk of hip fractures in postmenopausal women, making this risk especially noticeable in these women.17
Regular evaluation of bone health should be part of long-term care. Bone density scans might be advised, particularly for those who are at high risk. The severity of the thyroid condition and personal risk factors should be considered when deciding how frequently these scans should be performed.17
More importantly, bone density typically returns after thyroid function is under control. But in situations where patients need continuous thyroid hormone replacement (following radioactive iodine therapy or thyroidectomy), close observation is required to avoid overtreatment, which may also result in bone loss.17
About 25% of cases of Graves' disease include Graves' ophthalmopathy, a common extrathyroidal symptom of the condition. Thyroid storm individuals are susceptible to Graves' disease, but not all of them will develop it.18 Endocrinologists and ophthalmologists must work together in a multidisciplinary approach to treat Graves' ophthalmopathy. Even after thyroid function has stabilised, patients with Graves' disease should continue to have regular eye exams as part of their long-term follow-up.
It is important to note that moderate to severe active Graves' ophthalmopathy should not be treated with radioactive iodine therapy, a frequent treatment for Graves' disease, as this can make the condition worse.15 Therefore, the presence and severity of ophthalmopathy must be considered when choosing a definitive treatment for the underlying thyroid condition.
Lifestyle and supportive care
A comprehensive strategy that addresses lifestyle variables, supportive care, and the underlying thyroid condition is necessary for long-term management following a thyroid storm. Medication adherence is a critical component of therapy to maintain stable thyroid function. Levothyroxine therapy adherence among hypothyroid patients varies greatly, according to studies; some reports show adherence rates as low as 36.8%, while others show adherence rates as high as 78%.19 Adherence and treatment results can be greatly enhanced by teaching patients the value of regular medication consumption and follow-up visits with endocrinologists.20 Nutritional factors greatly influence thyroid health. Thyroid function benefits from a diet high in iodine, selenium, iron, zinc, and vitamins B12, D3, and A3. Specifically, the Mediterranean diet has been linked to better thyroid health because of its anti-inflammatory qualities and high content of vital minerals.21 Furthermore, patients must be getting enough calcium and vitamin D, particularly those at risk of osteoporosis because of thyroid dysfunction.
Long-term thyroid treatment requires mental health support and stress management, which are frequently disregarded but crucial. Thyroid diseases have been linked to stress, and treatments that aim to reduce stress have seen encouraging outcomes. Women who had Hashimoto's thyroiditis showed improvements in stress, anxiety, and depression levels as well as a drop in anti-thyroglobulin antibody titers after an 8-week stress management program.22 Inclusion of stress-reduction strategies and offering mental health assistance can greatly improve thyroid disease patients' general well-being.
Conclusion
Following a thyroid storm, long-term care necessitates a customised strategy based on the unique requirements of each patient and the underlying thyroid condition. Since treatment plans must consider the patient's medical history, response to prior treatments, and lifestyle, the significance of individualised care cannot be emphasised. Patients who have suffered from this potentially fatal illness are guaranteed better results and a higher quality of life thanks to this all-encompassing treatment.
Lifelong monitoring is often required, especially for patients who have had definitive procedures like thyroidectomy or radioactive iodine therapy. Maintaining ideal thyroid hormone balance and avoiding difficulties requires routine thyroid function testing, which includes measuring TSH, free T4, and T3 levels. To manage possible problems and avoid recurrence, patient education is essential. Patients must be aware of the significance of medication adherence, as research indicates that levothyroxine treatment adherence rates range greatly from 36.8% to 78% [8]. Early detection and treatments also depend on patients being informed about the symptoms of developing hypothyroidism or recurrent hyperthyroidism. Additionally, patients should be educated on lifestyle aspects that can affect thyroid health, such as the significance of routine follow-up consultations, stress management strategies, and nutritional concerns. Healthcare professionals can greatly lower the likelihood of recurrence and enhance long-term results for individuals who have had thyroid storms by educating patients and involving them in their care.
References
- Carroll R, Matfin G. Review: Endocrine and Metabolic Emergencies: Thyroid Storm. Therapeutic Advances in Endocrinology and Metabolism [Internet]. 2010 Aug;1(3):139–45. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475282/
- Hughes K, Eastman C. Thyroid disease Long term management of hyperthyroidism and hypothyroidism [Internet]. Australian Journal of General Practice. 2021. Available from: https://www1.racgp.org.au/ajgp/2021/january-february/thyroid-disease-long-term-management-of-hyperthyro
- Parasa M, Chinthakunta BK, Vemuri N, Shaik M. Out of the blue! Thyroid crisis. Anesthesia: Essays and Researches [Internet]. 2015 [cited 2022 Feb 27];0(0):0. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4383116/
- Medeiros-Neto G. Multinodular Goiter [Internet]. Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. PubMed. South Dartmouth (MA): MDText.com, Inc.; 2016. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285569/
- Massimo Tonacchera, Führer D. Toxic Adenoma and Multinodular Toxic Goiter. 2018 Jan 1;513–39. Available from: https://link.springer.com/referenceworkentry/10.1007/978-3-319-45013-1_18
- Kahaly George J, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce Simon H. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. European Thyroid Journal [Internet]. 2018;7(4):167–86. Available from: http://cmim.org/guias2019/14_ThyroidAssociationGuideline.pdf
- Oszukowska L, Knapska-Kucharska M, Lewiński A. Effects of drugs on the efficacy of radioiodine (131I) therapy in hyperthyroid patients. Archives of Medical Science [Internet]. 2010 [cited 2022 Oct 23];1:4–10. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3278936/
- Noureldine SI, Genther DJ, Lopez M, Agrawal N, Tufano RP. Early Predictors of Hypocalcemia After Total Thyroidectomy. JAMA Otolaryngology–Head & Neck Surgery [Internet]. 2014 Nov 1;140(11):1006. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4316663/
- Geffner DL, Hershman JM. Beta-adrenergic blockade for the treatment of hyperthyroidism. The American Journal of Medicine [Internet]. 1992 Jul 1;93(1):61–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed?term=1352658
- Farzam K, Jan A. Beta Blockers [Internet]. National Library of Medicine. StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532906/
- Almeida RD, McCalmon S, Cabandugama PK. Clinical Review and Update on the Management of Thyroid Storm. Missouri Medicine [Internet]. 2022 Jul;119(4):366. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9462913/
- Mathew P, Rawla P, Fortes K. Hyperthyroidism [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK568782/
- Feldt-Rasmussen U, Klose M. Clinical Strategies in the Testing of Thyroid Function [Internet]. Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. PubMed. South Dartmouth (MA): MDText.com, Inc.; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285558/
- Abe M, Matsuo Y, Horiuchi M, Kitamura K, Suzuki T. Successful Heart Rate Management of Atrial Fibrillation Due to Thyroid Storm Using Intravenous Amiodarone. Journal of Endocrinology and Metabolism [Internet]. 2023 [cited 2025 Mar 3];13(3):126–33. Available from: https://jofem.org/index.php/jofem/article/view/887/284284675
- Practitioners TRAC of general. Evaluating and managing patients with thyrotoxicosis [Internet]. Australian Family Physician. 2012. Available from: https://www.racgp.org.au/afp/2012/august/evaluating-and-managing-patients-with-thyrotoxicos
- Mansoor T, Kaur J, Randhawa M, Rai A, Yu D, Khan FI, et al. Iatrogenic cardiac arrest during thyroid storm. European Journal of Case Reports in Internal Medicine [Internet]. 2024 Nov 4 [cited 2025 Jan 20]; Available from: https://www.ejcrim.com/index.php/EJCRIM/article/view/4958
- Apostu D, Lucaciu O, Oltean-Dan D, Mureșan AD, Moisescu-Pop C, Maxim A, et al. The Influence of Thyroid Pathology on Osteoporosis and Fracture Risk: A Review. Diagnostics [Internet]. 2020 Mar 7;10(3):149. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7151086
- Graves’ disease - Symptoms, diagnosis and treatment | BMJ Best Practice [Internet]. bestpractice.bmj.com. Available from: https://bestpractice.bmj.com/topics/en-gb/32
- Cappelli C, Castello R, Marini F, Paoletta A, Marchetti M, Saullo M, et al. Adherence to Levothyroxine Treatment Among Patients With Hypothyroidism: A Northeastern Italian Survey. Frontiers in Endocrinology [Internet]. 2018 Nov 23;9. Available from: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2018.00699/full
- Kumar R, Shaukat F. Adherence to Levothyroxine Tablet in Patients with Hypothyroidism. Cureus [Internet]. 2019 May 8; Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6615580/
- Duntas LH. Nutrition and thyroid disease. Current Opinion in Endocrinology, Diabetes and Obesity [Internet]. 2023 Aug 15;30(6). Available from: https://pubmed.ncbi.nlm.nih.gov/37578378/
- Markomanolaki ZS, Tigani X, Siamatras T, Bacopoulou F, Athanasios Tsartsalis, Artemios Artemiadis, et al. Stress Management in Women with Hashimoto’s thyroiditis: A Randomized Controlled Trial. Journal of molecular biochemistry [Internet]. 2019;8(1):3. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6688766/

